| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Frontotemporal Dementia | 27 | 2025 | 157 | 4.820 |
Why?
|
| Amyotrophic Lateral Sclerosis | 21 | 2025 | 515 | 3.120 |
Why?
|
| C9orf72 Protein | 17 | 2024 | 114 | 2.550 |
Why?
|
| Neurons | 20 | 2025 | 933 | 2.100 |
Why?
|
| Induced Pluripotent Stem Cells | 17 | 2025 | 160 | 1.800 |
Why?
|
| Proteins | 13 | 2023 | 764 | 1.420 |
Why?
|
| Motor Neurons | 6 | 2024 | 218 | 1.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2017 | 156 | 1.400 |
Why?
|
| DNA Repeat Expansion | 11 | 2024 | 58 | 1.210 |
Why?
|
| Cerebral Cortex | 7 | 2016 | 269 | 0.940 |
Why?
|
| Propionates | 6 | 2011 | 24 | 0.910 |
Why?
|
| Mitochondria | 11 | 2019 | 410 | 0.880 |
Why?
|
| Apoptosis | 8 | 2011 | 1098 | 0.840 |
Why?
|
| Nitro Compounds | 6 | 2011 | 15 | 0.710 |
Why?
|
| Dipeptides | 6 | 2023 | 68 | 0.670 |
Why?
|
| Mutation | 9 | 2025 | 2661 | 0.660 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2016 | 38 | 0.610 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2009 | 34 | 0.600 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 100 | 0.580 |
Why?
|
| Hydroxamic Acids | 2 | 2016 | 29 | 0.560 |
Why?
|
| Huntington Disease | 5 | 2013 | 160 | 0.530 |
Why?
|
| Autophagy | 3 | 2016 | 237 | 0.500 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2016 | 15 | 0.470 |
Why?
|
| Cells, Cultured | 10 | 2019 | 2188 | 0.470 |
Why?
|
| Neural Stem Cells | 3 | 2021 | 47 | 0.420 |
Why?
|
| Caspases | 6 | 2009 | 176 | 0.410 |
Why?
|
| Genetic Therapy | 1 | 2020 | 839 | 0.370 |
Why?
|
| Animals | 26 | 2025 | 21345 | 0.360 |
Why?
|
| MicroRNAs | 3 | 2014 | 713 | 0.350 |
Why?
|
| Cell Line | 9 | 2019 | 2024 | 0.350 |
Why?
|
| DNA-Binding Proteins | 4 | 2025 | 1225 | 0.330 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.320 |
Why?
|
| Nerve Growth Factor | 1 | 2009 | 5 | 0.310 |
Why?
|
| Convulsants | 1 | 2009 | 7 | 0.310 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 15 | 0.310 |
Why?
|
| DNA Damage | 2 | 2025 | 297 | 0.310 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 152 | 0.300 |
Why?
|
| Tacrolimus | 2 | 2011 | 63 | 0.300 |
Why?
|
| Haploinsufficiency | 3 | 2021 | 20 | 0.290 |
Why?
|
| Humans | 38 | 2025 | 65140 | 0.290 |
Why?
|
| Cell Differentiation | 7 | 2016 | 1386 | 0.280 |
Why?
|
| Cell Death | 5 | 2016 | 289 | 0.280 |
Why?
|
| Cell Survival | 6 | 2016 | 587 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 341 | 0.280 |
Why?
|
| Leukocytes | 1 | 2008 | 105 | 0.270 |
Why?
|
| RNA | 3 | 2023 | 426 | 0.260 |
Why?
|
| Ku Autoantigen | 1 | 2025 | 7 | 0.240 |
Why?
|
| Sirtuin 1 | 1 | 2025 | 27 | 0.230 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 2293 | 0.230 |
Why?
|
| HEK293 Cells | 6 | 2021 | 616 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2025 | 318 | 0.220 |
Why?
|
| tau Proteins | 2 | 2016 | 210 | 0.220 |
Why?
|
| Down-Regulation | 3 | 2019 | 324 | 0.210 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1574 | 0.210 |
Why?
|
| Membrane Proteins | 2 | 2010 | 919 | 0.210 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 68 | 0.210 |
Why?
|
| Rats | 4 | 2009 | 1994 | 0.200 |
Why?
|
| Rats, Wistar | 3 | 2009 | 182 | 0.200 |
Why?
|
| Protein Biosynthesis | 3 | 2021 | 333 | 0.190 |
Why?
|
| Staurosporine | 4 | 2012 | 19 | 0.190 |
Why?
|
| Introns | 2 | 2021 | 114 | 0.190 |
Why?
|
| Heterozygote | 2 | 2013 | 173 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1630 | 0.180 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 21 | 0.180 |
Why?
|
| Enzyme Activation | 4 | 2016 | 391 | 0.170 |
Why?
|
| Drosophila | 6 | 2025 | 480 | 0.170 |
Why?
|
| Mice | 9 | 2022 | 11119 | 0.170 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 790 | 0.160 |
Why?
|
| Alternative Splicing | 1 | 2021 | 138 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 39 | 0.160 |
Why?
|
| Brain | 3 | 2019 | 1605 | 0.150 |
Why?
|
| Ribosomes | 1 | 2021 | 170 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2019 | 7 | 0.150 |
Why?
|
| Sequence Deletion | 1 | 2019 | 115 | 0.150 |
Why?
|
| Neurites | 2 | 2016 | 23 | 0.150 |
Why?
|
| Neurogenesis | 1 | 2019 | 64 | 0.140 |
Why?
|
| Microglia | 2 | 2012 | 250 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 81 | 0.140 |
Why?
|
| Lysosomes | 2 | 2017 | 173 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 104 | 0.140 |
Why?
|
| Acetylation | 2 | 2025 | 121 | 0.130 |
Why?
|
| Cathepsin L | 1 | 2017 | 21 | 0.130 |
Why?
|
| Neurotoxins | 3 | 2006 | 21 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 687 | 0.130 |
Why?
|
| Caspase 3 | 4 | 2011 | 108 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 29 | 0.120 |
Why?
|
| Drosophila Proteins | 2 | 2019 | 758 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 65 | 0.120 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 42 | 0.120 |
Why?
|
| Cellular Reprogramming | 2 | 2016 | 41 | 0.120 |
Why?
|
| Cytoplasmic Granules | 1 | 2015 | 52 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 369 | 0.120 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 13 | 0.120 |
Why?
|
| RNA Transport | 1 | 2015 | 31 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 203 | 0.110 |
Why?
|
| Inclusion Bodies | 1 | 2015 | 17 | 0.110 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 907 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2015 | 84 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 128 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 115 | 0.110 |
Why?
|
| Transfection | 3 | 2012 | 700 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2021 | 541 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2025 | 962 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 428 | 0.110 |
Why?
|
| Animals, Genetically Modified | 4 | 2016 | 312 | 0.110 |
Why?
|
| Receptors, Notch | 1 | 2015 | 110 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 42 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2014 | 63 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2016 | 321 | 0.110 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 61 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 351 | 0.100 |
Why?
|
| Social Behavior | 1 | 2014 | 85 | 0.100 |
Why?
|
| Drosophila melanogaster | 2 | 2016 | 559 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 856 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2013 | 81 | 0.100 |
Why?
|
| Electron Transport | 1 | 2013 | 29 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 14 | 0.090 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2010 | 20 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 22 | 0.090 |
Why?
|
| Pyridines | 1 | 2013 | 119 | 0.090 |
Why?
|
| Endocytosis | 1 | 2013 | 152 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2014 | 234 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 852 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2013 | 108 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2010 | 48 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 44 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2019 | 1556 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2013 | 209 | 0.090 |
Why?
|
| Organelles | 1 | 2011 | 21 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 602 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 79 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 213 | 0.090 |
Why?
|
| Genotype | 1 | 2013 | 673 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 197 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2012 | 127 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 100 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 78 | 0.080 |
Why?
|
| Corpus Striatum | 1 | 2011 | 98 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 367 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2012 | 1038 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 154 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 177 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 205 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 405 | 0.080 |
Why?
|
| Biomarkers | 2 | 2016 | 1480 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 1290 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 195 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2011 | 374 | 0.080 |
Why?
|
| Anilides | 1 | 2009 | 18 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 482 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 1 | 2009 | 18 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 447 | 0.080 |
Why?
|
| Multienzyme Complexes | 1 | 2010 | 87 | 0.080 |
Why?
|
| Cytochromes c | 1 | 2009 | 28 | 0.080 |
Why?
|
| Succinate Dehydrogenase | 1 | 2009 | 16 | 0.080 |
Why?
|
| Central Nervous System Agents | 1 | 2009 | 11 | 0.070 |
Why?
|
| Histone Acetyltransferases | 1 | 2009 | 59 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2016 | 611 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 380 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2009 | 135 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 109 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 215 | 0.070 |
Why?
|
| Cytosol | 2 | 2011 | 182 | 0.070 |
Why?
|
| Female | 6 | 2025 | 34018 | 0.070 |
Why?
|
| Male | 8 | 2025 | 31047 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 235 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 237 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1565 | 0.060 |
Why?
|
| Protein Binding | 1 | 2011 | 1640 | 0.060 |
Why?
|
| Neostriatum | 1 | 2006 | 26 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 90 | 0.060 |
Why?
|
| Monocytes | 1 | 2008 | 361 | 0.060 |
Why?
|
| Histones | 1 | 2009 | 494 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 164 | 0.060 |
Why?
|
| Neutrophils | 1 | 2008 | 395 | 0.060 |
Why?
|
| Eye | 2 | 2015 | 59 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 321 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2009 | 718 | 0.050 |
Why?
|
| Pregnancy | 1 | 2012 | 2372 | 0.050 |
Why?
|
| Chromatin | 1 | 2009 | 641 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 158 | 0.050 |
Why?
|
| DNA Fragmentation | 3 | 2011 | 34 | 0.050 |
Why?
|
| Retina | 1 | 2003 | 132 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 13 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 52 | 0.050 |
Why?
|
| Dinucleotide Repeats | 1 | 2021 | 7 | 0.040 |
Why?
|
| Calcium | 3 | 2014 | 584 | 0.040 |
Why?
|
| Qa-SNARE Proteins | 1 | 2021 | 19 | 0.040 |
Why?
|
| Astrocytes | 1 | 2022 | 123 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 2021 | 50 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2016 | 201 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 2011 | 67 | 0.040 |
Why?
|
| Phenotype | 2 | 2015 | 1233 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 14965 | 0.040 |
Why?
|
| GC Rich Sequence | 1 | 2019 | 4 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 372 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 97 | 0.040 |
Why?
|
| Axons | 1 | 2019 | 124 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 111 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2010 | 33 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 2017 | 12 | 0.030 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2017 | 20 | 0.030 |
Why?
|
| Time Factors | 3 | 2011 | 3762 | 0.030 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2016 | 3 | 0.030 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 13 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 48 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 59 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 80 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 238 | 0.030 |
Why?
|
| Arginine | 1 | 2016 | 136 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 99 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 53 | 0.030 |
Why?
|
| Nuclear Pore | 1 | 2015 | 23 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2015 | 45 | 0.030 |
Why?
|
| Wings, Animal | 1 | 2015 | 28 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 184 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 268 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 18273 | 0.030 |
Why?
|
| Muscles | 1 | 2015 | 179 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 210 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 127 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 345 | 0.020 |
Why?
|
| Zebrafish | 1 | 2016 | 374 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 449 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 104 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 394 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 94 | 0.020 |
Why?
|
| Centrosome | 1 | 2011 | 72 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 1332 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2157 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 148 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2011 | 147 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2013 | 399 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2010 | 5 | 0.020 |
Why?
|
| Nitrobenzoates | 1 | 2010 | 5 | 0.020 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2010 | 4 | 0.020 |
Why?
|
| Teratocarcinoma | 1 | 2010 | 4 | 0.020 |
Why?
|
| Electron Transport Complex III | 1 | 2010 | 5 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 450 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 16 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 32 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 31 | 0.020 |
Why?
|
| Superoxides | 1 | 2010 | 73 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 182 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2010 | 33 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 981 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 500 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5614 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 706 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 345 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2010 | 86 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1698 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 402 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 643 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 18 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2007 | 11 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 38 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1141 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 67 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 301 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 3153 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 896 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 17358 | 0.010 |
Why?
|
| Metalloporphyrins | 1 | 2003 | 3 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2003 | 5 | 0.010 |
Why?
|
| Oligomycins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 14 | 0.010 |
Why?
|
| Rotenone | 1 | 2003 | 6 | 0.010 |
Why?
|
| Xanthine Oxidase | 1 | 2003 | 11 | 0.010 |
Why?
|
| Allopurinol | 1 | 2003 | 15 | 0.010 |
Why?
|
| Chromans | 1 | 2003 | 16 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 47 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2003 | 46 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2003 | 14 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 45 | 0.010 |
Why?
|
| Indazoles | 1 | 2003 | 19 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 2003 | 27 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 45 | 0.010 |
Why?
|
| Ubiquinone | 1 | 2003 | 20 | 0.010 |
Why?
|
| Glutathione | 1 | 2003 | 55 | 0.010 |
Why?
|
| Adenine | 1 | 2003 | 48 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 50 | 0.010 |
Why?
|
| Carbon | 1 | 2003 | 52 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2003 | 134 | 0.010 |
Why?
|
| Antioxidants | 1 | 2003 | 249 | 0.010 |
Why?
|